Published in Acta Biomater on November 10, 2012
Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems. Chem Soc Rev (2016) 1.08
Biomaterials for mRNA delivery. Biomater Sci (2015) 0.87
Liposome-like Nanostructures for Drug Delivery. J Mater Chem B Mater Biol Med (2013) 0.87
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come. Pharmacol Rev (2016) 0.84
Current advances in polymer-based nanotheranostics for cancer treatment and diagnosis. ACS Appl Mater Interfaces (2014) 0.81
Ultra-small lipid-polymer hybrid nanoparticles for tumor-penetrating drug delivery. Nanoscale (2016) 0.77
Doxorubicin-loaded aromatic imine-contained amphiphilic branched star polymer micelles: synthesis, self-assembly, and drug delivery. Int J Nanomedicine (2015) 0.75
Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release. J Vis Exp (2016) 0.75
Triggered Release of Encapsulated Cargo from Photoresponsive Polyelectrolyte Nanocomplexes. ACS Appl Mater Interfaces (2016) 0.75
In situ formation of magnetopolymersomes via electroporation for MRI. Sci Rep (2015) 0.75
Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov (2008) 12.72
Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A (1998) 7.78
Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther (2007) 5.79
Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev (2004) 5.31
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials (2006) 4.09
The emerging nanomedicine landscape. Nat Biotechnol (2006) 3.60
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano (2008) 2.76
Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv Drug Deliv Rev (2006) 2.69
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci U S A (2011) 2.37
PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials (2008) 2.21
Emerging implications of nanotechnology on cancer diagnostics and therapeutics. Cancer (2006) 2.04
Nanotechnology: intelligent design to treat complex disease. Pharm Res (2006) 1.95
In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams. Biomaterials (2000) 1.85
Nanoparticle-based diagnosis and therapy. Curr Drug Targets (2006) 1.70
Spatiotemporal controlled delivery of nanoparticles to injured vasculature. Proc Natl Acad Sci U S A (2010) 1.64
Active targeting of brain tumors using nanocarriers. Biomaterials (2007) 1.42
Nanoparticle-mediated drug delivery and gene therapy. Biotechnol Prog (2007) 1.34
Biofunctionalized targeted nanoparticles for therapeutic applications. Expert Opin Biol Ther (2008) 1.30
Magnetically enhanced insulin release in diabetic rats. J Biomed Mater Res (1987) 1.21
Photoresponsive polymer-enzyme switches. Proc Natl Acad Sci U S A (2002) 1.19
Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel. Biomaterials (2009) 1.18
Magnetically vectored nanocapsules for tumor penetration and remotely switchable on-demand drug release. Nano Lett (2010) 1.17
Quick synthesis of lipid-polymer hybrid nanoparticles with low polydispersity using a single-step sonication method. Langmuir (2010) 1.14
Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapy. Mol Pharm (2011) 1.11
Metallic colloid nanotechnology, applications in diagnosis and therapeutics. Curr Pharm Des (2005) 1.01
Acidic hydrolysis of N-Ethoxybenzylimidazoles (NEBIs): potential applications as pH-sensitive linkers for drug delivery. Bioconjug Chem (2007) 0.88
pH-Sensitive, N-ethoxybenzylimidazole (NEBI) bifunctional crosslinkers enable triggered release of therapeutics from drug delivery carriers. Org Biomol Chem (2010) 0.86
The next generation of liposome delivery systems: recent experience with tumor-targeted, sterically-stabilized immunoliposomes and active-loading gradients. J Liposome Res (2003) 0.82
Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. Nature (2011) 4.57
Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res (2007) 4.48
Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling. Nat Immunol (2008) 4.33
Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc Natl Acad Sci U S A (2008) 3.80
Stem cell fate dictated solely by altered nanotube dimension. Proc Natl Acad Sci U S A (2009) 3.73
Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex. Science (2008) 2.99
Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev (2009) 2.57
Biosensing using porous silicon double-layer interferometers: reflective interferometric Fourier transform spectroscopy. J Am Chem Soc (2005) 2.56
Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nat Immunol (2009) 2.52
Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Lett (2007) 2.40
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci U S A (2011) 2.37
PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials (2008) 2.21
Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials (2007) 1.97
Nanoparticle-induced surface reconstruction of phospholipid membranes. Proc Natl Acad Sci U S A (2008) 1.90
Micromachine-enabled capture and isolation of cancer cells in complex media. Angew Chem Int Ed Engl (2011) 1.87
A biomimetic nanosponge that absorbs pore-forming toxins. Nat Nanotechnol (2013) 1.70
Improved bone-forming functionality on diameter-controlled TiO(2) nanotube surface. Acta Biomater (2009) 1.68
Nanoparticle-based combination therapy toward overcoming drug resistance in cancer. Biochem Pharmacol (2012) 1.68
Spatiotemporal controlled delivery of nanoparticles to injured vasculature. Proc Natl Acad Sci U S A (2010) 1.64
RACK1 mediates activation of JNK by protein kinase C [corrected]. Mol Cell (2005) 1.59
Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy. ChemMedChem (2008) 1.57
Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett (2014) 1.55
Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma. Nat Rev Drug Discov (2012) 1.52
Nanoparticle-detained toxins for safe and effective vaccination. Nat Nanotechnol (2013) 1.50
Significantly accelerated osteoblast cell growth on aligned TiO2 nanotubes. J Biomed Mater Res A (2006) 1.47
Growth of nano-scale hydroxyapatite using chemically treated titanium oxide nanotubes. Biomaterials (2005) 1.42
Regulation of cancer cell survival, migration, and invasion by Twist: AKT2 comes to interplay. Cancer Res (2008) 1.42
Titanium dioxide nanotubes enhance bone bonding in vivo. J Biomed Mater Res A (2010) 1.36
Nanoparticle-assisted combination therapies for effective cancer treatment. Ther Deliv (2010) 1.35
Single-step assembly of homogenous lipid-polymeric and lipid-quantum dot nanoparticles enabled by microfluidic rapid mixing. ACS Nano (2010) 1.35
Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups. Biomaterials (2009) 1.35
Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris. J Invest Dermatol (2009) 1.35
Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery. Curr Cancer Drug Targets (2008) 1.33
Chronic lymphocytic leukemia of Emu-TCL1 transgenic mice undergoes rapid cell turnover that can be offset by extrinsic CD257 to accelerate disease progression. Blood (2009) 1.32
Biofunctionalized targeted nanoparticles for therapeutic applications. Expert Opin Biol Ther (2008) 1.30
Enhanced cellular mobility guided by TiO2 nanotube surfaces. Nano Lett (2008) 1.30
'Marker-of-self' functionalization of nanoscale particles through a top-down cellular membrane coating approach. Nanoscale (2013) 1.28
Sebum free fatty acids enhance the innate immune defense of human sebocytes by upregulating beta-defensin-2 expression. J Invest Dermatol (2009) 1.23
Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies. Nanoscale (2013) 1.20
TiO2 nanotubes for bone regeneration. Trends Biotechnol (2012) 1.20
Erythrocyte-inspired delivery systems. Adv Healthc Mater (2012) 1.20
Magnetically vectored nanocapsules for tumor penetration and remotely switchable on-demand drug release. Nano Lett (2010) 1.17
Complement factor H genotypes impact risk of age-related macular degeneration by interaction with oxidized phospholipids. Proc Natl Acad Sci U S A (2012) 1.16
Quick synthesis of lipid-polymer hybrid nanoparticles with low polydispersity using a single-step sonication method. Langmuir (2010) 1.14
Half-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells. Mol Pharm (2010) 1.14
Polymer--cisplatin conjugate nanoparticles for acid-responsive drug delivery. ACS Nano (2010) 1.12
Polymeric nanoparticles for drug delivery. Methods Mol Biol (2010) 1.12
Artificial micromotors in the mouse's stomach: a step toward in vivo use of synthetic motors. ACS Nano (2015) 1.11
Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapy. Mol Pharm (2011) 1.11
The antimicrobial activity of liposomal lauric acids against Propionibacterium acnes. Biomaterials (2009) 1.10
Rapid delivery of drug carriers propelled and navigated by catalytic nanoshuttles. Small (2010) 1.10
Stimuli-responsive liposome fusion mediated by gold nanoparticles. ACS Nano (2010) 1.10
Lipid- and polymer-based nanostructures for cancer theranostics. Theranostics (2012) 1.09
Therapeutic nanoparticles to combat cancer drug resistance. Curr Drug Metab (2009) 1.08
Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection. J Am Chem Soc (2011) 1.08
Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids. Biomaterials (2010) 1.08
Quantum dot applications to neuroscience: new tools for probing neurons and glia. J Neurosci (2006) 1.06
Carbon nanotubes: how strong is their bond with the substrate? ACS Nano (2011) 1.06
Cargo-towing fuel-free magnetic nanoswimmers for targeted drug delivery. Small (2011) 1.06
Propionibacterium acnes CAMP factor and host acid sphingomyelinase contribute to bacterial virulence: potential targets for inflammatory acne treatment. PLoS One (2011) 1.04
Combinatorial drug conjugation enables nanoparticle dual-drug delivery. Small (2010) 1.04
HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy. ChemMedChem (2008) 1.03
Inflammasomes in cancer: a double-edged sword. Protein Cell (2014) 1.01
Surface functionalization of gold nanoparticles with red blood cell membranes. Adv Mater (2013) 0.97
Modulating antibacterial immunity via bacterial membrane-coated nanoparticles. Nano Lett (2015) 0.97
Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles. Nanoscale (2014) 0.97
Antibacterial activities of liposomal linolenic acids against antibiotic-resistant Helicobacter pylori. Mol Pharm (2012) 0.97
Iron-platinum-coated carbon nanocone probes on tipless cantilevers for high resolution magnetic force imaging. Nanotechnology (2008) 0.95
Magnetic targeting of nanoparticles across the intact blood-brain barrier. J Control Release (2012) 0.95
ROR1, an embryonic protein with an emerging role in cancer biology. Protein Cell (2014) 0.95
Hydrophobic nanopillars initiate mesenchymal stem cell aggregation and osteo-differentiation. Acta Biomater (2010) 0.94
Beneficial and Detrimental Roles of NLRs in Carcinogenesis. Front Immunol (2013) 0.94
Development of a new minipig model to study radiation-induced gastrointestinal syndrome and its application in clinical research. Radiat Res (2014) 0.93
Methods to track single-molecule trajectories. Langmuir (2006) 0.93
Find and replace: editing human genome in pluripotent stem cells. Protein Cell (2011) 0.93
Erythrocyte membrane-cloaked polymeric nanoparticles for controlled drug loading and release. Nanomedicine (Lond) (2013) 0.92
Bacterial diversity of the Inner Mongolian Baer Soda Lake as revealed by 16S rRNA gene sequence analyses. Extremophiles (2003) 0.91
Fabrication of silicon nanopillar teradot arrays by electron-beam patterning for nanoimprint molds. Small (2008) 0.91
3D Branched nanowire photoelectrochemical electrodes for efficient solar water splitting. ACS Nano (2013) 0.90
Atomic force microscopy imaging and electrical recording of lipid bilayers supported over microfabricated silicon chip nanopores: lab-on-a-chip system for lipid membranes and ion channels. Langmuir (2007) 0.90
Comparative cell behavior on carbon-coated TiO2 nanotube surfaces for osteoblasts vs. osteo-progenitor cells. Acta Biomater (2011) 0.90
An IKKα-E2F1-BMI1 cascade activated by infiltrating B cells controls prostate regeneration and tumor recurrence. Genes Dev (2013) 0.90
An innate bactericidal oleic acid effective against skin infection of methicillin-resistant Staphylococcus aureus: a therapy concordant with evolutionary medicine. J Microbiol Biotechnol (2011) 0.89
Hydrogel containing nanoparticle-stabilized liposomes for topical antimicrobial delivery. ACS Nano (2014) 0.89
Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles. Nanoscale (2013) 0.89
Nanoparticles disguised as red blood cells to evade the immune system. Expert Opin Biol Ther (2012) 0.89
Lipid-coated polymeric nanoparticles for cancer drug delivery. Biomater Sci (2015) 0.87
Dual effects and mechanism of TiO2 nanotube arrays in reducing bacterial colonization and enhancing C3H10T1/2 cell adhesion. Int J Nanomedicine (2013) 0.87
Real-time electrochemical monitoring of drug release from therapeutic nanoparticles. J Control Release (2009) 0.87
ChemoRad nanoparticles: a novel multifunctional nanoparticle platform for targeted delivery of concurrent chemoradiation. Nanomedicine (Lond) (2010) 0.87